OINDPnews


Aptar Pharma banner

People

Iconovo appoints Mikael Ekström as VP of Development

Device developer Iconovo AB has announced the appointment of Mikael Ekström as its new VP, Development effective September 1, 2018. Ekström held various positions at AstraZeneca over a period of almost 30 years, most recently as Senior Director Inhalation Product Development. Iconovo said that Ekström's hire "is an important reinforcement of Iconovo's organization … [Read more...] about Iconovo appoints Mikael Ekström as VP of Development

Rick Batycky to leave Acorda ahead of FDA decision on Inbrija

Acorda Therapeutics has announced that Chief Technology Officer Rick Batycky is leaving the company as of August 20, 2018 to head up a new private biotech firm. Batycky co-founded Civitas Therapeutics, which was acquired by Acorda in 2014, along with its CVT-301 levodopa DPI, (now known as Inbrija) and the ARCUS dry powder inhalation platform. The company filed … [Read more...] about Rick Batycky to leave Acorda ahead of FDA decision on Inbrija

Proveris hires John Masciola as VP of Product Development

Proveris Scientific Corporation has announced the appointment of John Masciola as VP of Product Development. Masciola was most recently Engineering Manager at Parker Precision Fluidics, and his experience in the life sciences industry includes positions as Director of Instrument Engineering and Director of R&D at Perkin Elmer and VP of Engineering at Zymark/Caliper … [Read more...] about Proveris hires John Masciola as VP of Product Development

Savara acquires rights to inhaled antibiotic, appoints new strategic advisor, and provides update on Molgradex development

Savara has acquired rights to an amikacin/fosfomycin inhalation solution that was being developed by Cardeas Pharma for the treatment of ventilator associated pneumonia and has appointed former Cardeas Pharma CEO A. Bruce Montgomery as a strategic advisor, the company said. The company also announced a public offering of common stock, with shares priced at $11.50 … [Read more...] about Savara acquires rights to inhaled antibiotic, appoints new strategic advisor, and provides update on Molgradex development

Impel NeuroPharma names Lynn Gold Senior VP of Regulatory Affairs

Intranasal drug developer Impel NeuroPharma has hired Lynn C. Gold as Senior VP of Regulatory Affairs, the company said. Gold was most recently VP of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services and had previously served as VP of Research and Process Development at Sonus Pharmaceuticals. In 2017, Impel announced that it had signed service … [Read more...] about Impel NeuroPharma names Lynn Gold Senior VP of Regulatory Affairs

Per Bäckman joins Emmace Consulting

Former Mylan Senior Director of Inhalation Biopharmaceutics Per Bäckman has joined Emmace Consulting as Senior Inhalation Consultant, the company has announced. Bäckman also previously held various positions at AstraZeneca, including as Principal Scientist in Inhalation Biopharmaceutics, and at Novo Nordisk. Emmace Consulting CEO Mårten Svensson said, "Per Bäckman … [Read more...] about Per Bäckman joins Emmace Consulting

Galecto Biotech names Richard Marshall as Chief Medical Officer

Galecto Biotech, which is developing an inhaled galectin-3 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF), has hired former GSK VP and Head of the Fibrosis & Lung Injury Discovery Performance Unit Richard Marshall as its Chief Medical Officer, the company said. Marshall held a number of positions in respiratory drug development at GSK over 15 … [Read more...] about Galecto Biotech names Richard Marshall as Chief Medical Officer

Liquidia Technologies appoints Jeri Thomas Senior VP, Commercial

Liquidia Technologies has named Jeri Thomas as its new Senior VP Commercial, responsible initially for commercial plans for the company's LIQ861 treprostinil DPI, which is currently in Phase 3 development for the treatment of pulmonary arterial hypertension (PAH). According to Liquidia, Thomas was most recently Senior VP, Strategic Group Planning at healthcare … [Read more...] about Liquidia Technologies appoints Jeri Thomas Senior VP, Commercial